Insights

Certifications & Inspections GCP/GLP/GMP-certified with EMA and FDA inspections, including two onsite FDA inspections in 2025, signaling strong compliance and reliability for pharma partners seeking high-quality CRO services.

InHouse Capacity Extensive in-house capabilities across clinical testing, bioanalytics, quality control, and R&D with multiple clinical units and 60+36 bed capacity, enabling end-to-end support from early development to market release.

UHPLC Advancement Recent UHPLC toolset expansion positions Quinta as a leader in advanced analytical chromatography, offering faster, higher-resolution analyses to accelerate development timelines.

Global CRO Partnerships Global support across drug development lifecycle for small molecules, biologics, biosimilars, generics, and IMPs for human and veterinary use, appealing to biotech and pharma clients seeking a broad, integrated partner.

Financial Footprint Mid-market revenue profile with $1M–$10M range indicates growth potential for scale-up engagements, especially with expanded service lines and capacity in analytical testing and QC.

Similar companies to QUINTA-ANALYTICA

QUINTA-ANALYTICA Tech Stack

QUINTA-ANALYTICA uses 8 technology products and services including LinkedIn Ads, Amazon Web Services, WordPress, and more. Explore QUINTA-ANALYTICA's tech stack below.

QUINTA-ANALYTICA's Email Address Formats

QUINTA-ANALYTICA uses at least 2 email formats:
QUINTA-ANALYTICA Email FormatsExamplePercentage
First.Last@quinta.czJohn.Doe@quinta.cz
96%
First@quinta.czJohn@quinta.cz
4%

Frequently Asked Questions

What is QUINTA-ANALYTICA's phone number?

Minus sign iconPlus sign icon
You can contact QUINTA-ANALYTICA's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is QUINTA-ANALYTICA's official website and social media links?

Minus sign iconPlus sign icon
QUINTA-ANALYTICA's official website is quinta.cz and has social profiles on LinkedIn.

How much revenue does QUINTA-ANALYTICA generate?

Minus sign iconPlus sign icon
As of August 2026, QUINTA-ANALYTICA's annual revenue is estimated to be $1M - $10M.

What is QUINTA-ANALYTICA's SIC code and NAICS code?

Minus sign iconPlus sign icon
QUINTA-ANALYTICA's SIC code is 7299 - Miscellaneous Personal Services, Not Elsewhere Classified and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does QUINTA-ANALYTICA have currently?

Minus sign iconPlus sign icon
As of August 2026, QUINTA-ANALYTICA has approximately 180 employees across 1 continents, including Asia. Key team members include Ceo: R. G., Chief Financial Officer: M. M. and Head Of Qa Unit: R. V. Explore QUINTA-ANALYTICA's employee directory with LeadIQ.

What industry does QUINTA-ANALYTICA belong to?

Minus sign iconPlus sign icon
QUINTA-ANALYTICA operates in the Pharmaceutical Manufacturing industry.

What technology does QUINTA-ANALYTICA use?

Minus sign iconPlus sign icon
QUINTA-ANALYTICA's tech stack includes LinkedIn Ads, Amazon Web Services, WordPress, Cookiebot, Osano, Shopify, Microsoft 365 and Webflow.

What is QUINTA-ANALYTICA's email format?

Minus sign iconPlus sign icon
QUINTA-ANALYTICA's email format typically follows the pattern of First.Last@quinta.cz. Find more QUINTA-ANALYTICA email formats with LeadIQ.

When was QUINTA-ANALYTICA founded?

Minus sign iconPlus sign icon
QUINTA-ANALYTICA was founded in 1997.
QUINTA-ANALYTICA logo

QUINTA-ANALYTICA

Pharmaceutical ManufacturingPrague, Czech Republic51-200 Employees

Quinta-Analytica is a European contract research organization focused on pharmaceutical development, holding GCP, GLP, and GMP certifications and EMA- and FDA-inspection history. The company delivers fully in-house services across clinical testing, bioanalytics, pharmaceutical quality control, and analytical R&D/CMC support for a range of products including small molecules, biologics and biosimilars, generics, and human and veterinary IMPs. Founded in 1997 and headquartered in Prague, Czechia, it operates as part of the Conscio Group, which is based in Germany.

Its global pharma and biotech clients work with Quinta across the drug development lifecycle, from early development through clinical trials, regulatory submissions, and market release. Quinta maintains two in-house clinical units for BE/BA/PK studies, with capacity for up to 96 beds, and provides GLP/GCP bioanalytical testing, GMP quality control, and microbiology and sterility services, along with CMC characterization for peptide and protein IMPs and other QC activities. In 2025 the company underwent two onsite FDA inspections, reflecting ongoing regulatory capability.

Section iconCompany Overview

Phone number
Website
quinta.cz
SIC Code
7299 - Miscellaneous Personal Services, Not Elsewhere Classified
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1997
Employees
51-200

Section iconFunding & Financials

  • $1M - $10M

    QUINTA-ANALYTICA's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.